IL6 and major depressive disorder: We have previously observed increased levels of circulating innate immune cells (i.e., monocytes and neutrophils), elevated levels of the proinflammatory cytokine interleukin-6 (IL-6), and blood-brain barrier (BBB) dysfunction in the CSDS model and in patients with MDD (19, 20).